The capacity to produce IFN-γ rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice

被引:70
作者
Lehmann, J
Enssle, KH
Lehmann, I
Emmendörfer, A
Lohmann-Matthes, ML
机构
[1] Fraunhofer Inst Toxicol & Aerosol Res, Dept Immunobiol, D-3000 Hannover, Germany
[2] Behringwerke AG, D-3550 Marburg, Germany
[3] Univ Leipzig, Inst Clin Immunol & Transfus Med, D-7010 Leipzig, Germany
关键词
D O I
10.1089/107999000312748
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The immune response against Leishmania donovani infection has been investigated in one resistant mouse strain (C3H/HeJ) and three susceptible mouse strains (C57BL/6, BALB/c, and B10D2/n), In order to correlate the strain-specific course of infection with the individual T cell response phenotype, the ex vivo cytokine secretion patterns of splenic lymphocytes were assessed by ELISA (interferon-gamma [IFN-gamma], interleukin-4 [IL-4], IL-10) or by bioassay (IL-2), The strain-dependent differences in the course of infection correlated closely with the potency of T cells to produce IFN-gamma, C3H/HeJ mice produced high amounts of IFN-gamma before and during infection, whereas susceptible mice produced low amounts of IFN-gamma early during L, donovani infection. However, C57BL/6 mice, which recovered from the infection rapidly after the acute stage, developed marked IFN-gamma response within the first 30 days of infection. In contrast, in BALB/c and B10D2/n mice, the IFN-gamma production diminished during the acute stage, and this was associated with a delay in recovery and with subsequent switching into the chronic stage. Interestingly, CD8(+) T cells contributed significantly to IFN-gamma production during this phase. In contrast to IFN-gamma, the levels of IL-4 in response to antigen or mitogen ex vivo were always very low. Moreover, neutralization of endogenous IL-4 in vivo by treatment with soluble murine IL-4 receptor did not result in significant decreases in the parasite burdens in spleen and liver but did cause a decrease in the serum IgE level of L. donovani-infected BALB/c mice. These results confirm that in visceral leishmaniasis a Th1-dominated immune response is protective against the L. donovani parasites and, furthermore, that the capacity to produce IFN-gamma rather than the presence of IL-4 determines the efficacy of the immune response in susceptible mice. The data show that CD8(+) T cells represent an important source of IFN-gamma during L, donovani infection in susceptible mice, implying a role for this cell type in healing and development of protective immunity.
引用
收藏
页码:63 / 77
页数:15
相关论文
共 34 条
[1]   EASILY PREPARED DEFINED MEDIUM FOR CULTIVATION OF LEISHMANIA-DONOVANI PROMASTIGOTES [J].
BERENS, RL ;
MARR, JJ .
JOURNAL OF PARASITOLOGY, 1978, 64 (01) :160-160
[2]  
CHATELAIN R, 1992, J IMMUNOL, V148, P1182
[3]  
Engwerda CR, 1998, EUR J IMMUNOL, V28, P669, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt
[4]  
669::AID-IMMU669&gt
[5]  
3.0.CO
[6]  
2-N
[7]   RECOMBINANT SOLUBLE INTERLEUKIN-4 (IL-4) RECEPTOR ACTS AS AN ANTAGONIST OF IL-4 IN MURINE CUTANEOUS LEISHMANIASIS [J].
GESSNER, A ;
SCHROPPEL, K ;
WILL, A ;
ENSSLE, KH ;
LAUFFER, L ;
ROLLINGHOFF, M .
INFECTION AND IMMUNITY, 1994, 62 (10) :4112-4117
[8]   INTERLEUKIN-10 PRODUCTION CORRELATES WITH PATHOLOGY IN HUMAN LEISHMANIA-DONOVANI INFECTIONS [J].
GHALIB, HW ;
PIUVEZAM, MR ;
SKEIKY, YAW ;
SIDDIG, M ;
HASHIM, FA ;
ELHASSAN, AM ;
RUSSO, DM ;
REED, SG .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :324-329
[9]   EXPRESSION CLONING OF A CDNA-ENCODING THE MURINE INTERLEUKIN-4 RECEPTOR BASED ON LIGAND-BINDING [J].
HARADA, N ;
CASTLE, BE ;
GORMAN, DM ;
ITOH, N ;
SCHREURS, J ;
BARRETT, RL ;
HOWARD, M ;
MIYAJIMA, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) :857-861
[10]   RECIPROCAL EXPRESSION OF INTERFERON-GAMMA OR INTERLEUKIN-4 DURING THE RESOLUTION OR PROGRESSION OF MURINE LEISHMANIASIS - EVIDENCE FOR EXPANSION OF DISTINCT HELPER T-CELL SUBSETS [J].
HEINZEL, FP ;
SADICK, MD ;
HOLADAY, BJ ;
COFFMAN, RL ;
LOCKSLEY, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) :59-72